![Frontiers | Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China Frontiers | Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China](https://www.frontiersin.org/files/Articles/741671/fphar-12-741671-HTML-r1/image_m/fphar-12-741671-t004.jpg)
Frontiers | Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
![A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems. - Abstract - Europe PMC A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9245041/bin/fmedt-04-888404-g0003.jpg)
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems. - Abstract - Europe PMC
![PDF] Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis | Semantic Scholar PDF] Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/506ab86d6b03ac2e291955dd7a0e29a1454b191e/5-Table1-1.png)
PDF] Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis | Semantic Scholar
![Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries | Orphanet Journal of Rare Diseases Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries | Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1750-1172-8-198/MediaObjects/13023_2013_Article_688_Fig1_HTML.jpg)
Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries | Orphanet Journal of Rare Diseases
Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments
![International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market | International Journal of Technology Assessment in Health Care | Cambridge Core International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market | International Journal of Technology Assessment in Health Care | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210602170416638-0064:S0266462320000653:S0266462320000653_tab1.png?pub-status=live)
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market | International Journal of Technology Assessment in Health Care | Cambridge Core
![Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10198-014-0626-0/MediaObjects/10198_2014_626_Fig1_HTML.gif)
Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics
![Legemiddeløkonomiseminar Karianne Johansen Legemiddelindustriforeningen, LMI 2. desember ppt download Legemiddeløkonomiseminar Karianne Johansen Legemiddelindustriforeningen, LMI 2. desember ppt download](https://images.slideplayer.com/15/4690245/slides/slide_10.jpg)
Legemiddeløkonomiseminar Karianne Johansen Legemiddelindustriforeningen, LMI 2. desember ppt download
![Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10198-014-0626-0/MediaObjects/10198_2014_626_Fig5_HTML.gif)
Using price–volume agreements to manage pharmaceutical leakage and off-label promotion | The European Journal of Health Economics
![Cyber Perpetual Contracts Boast 19% Trading Volume Increase: The Fundamentals of Cyber Perpetual Contracts Cyber Perpetual Contracts Boast 19% Trading Volume Increase: The Fundamentals of Cyber Perpetual Contracts](https://cdn.publish0x.com/prod/fs/images/fe7828db736e6a03e4d21451ce6aba6551d1ad7cc634e39f15c89cdc46f88e62.png)
Cyber Perpetual Contracts Boast 19% Trading Volume Increase: The Fundamentals of Cyber Perpetual Contracts
![Energies | Free Full-Text | Accelerating the Energy Transition through Power Purchase Agreement Design: A Philippines Off-Grid Case Study Energies | Free Full-Text | Accelerating the Energy Transition through Power Purchase Agreement Design: A Philippines Off-Grid Case Study](https://www.mdpi.com/energies/energies-16-06645/article_deploy/html/images/energies-16-06645-g001.png)